These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 19914559)

  • 1. Randomized clinical trials in breast cancer.
    Crago AM; Azu M; Tierney S; Morrow M
    Surg Oncol Clin N Am; 2010 Jan; 19(1):33-58. PubMed ID: 19914559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National Institutes of Health Consensus Development Conference statement: adjuvant therapy for breast cancer, November 1-3, 2000.
    National Institutes of Health Consensus Development Panel
    J Natl Cancer Inst Monogr; 2001; (30):5-15. PubMed ID: 11773285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are all aromatase inhibitors the same? A review of controlled clinical trials in breast cancer.
    Berry J
    Clin Ther; 2005 Nov; 27(11):1671-84. PubMed ID: 16368441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evidence-based radiotherapy in the treatment of operable breast cancer: results in the 1990-ies].
    Fodor J; Polgár C; Németh G
    Orv Hetil; 2000 Jul; 141(28):1551-5. PubMed ID: 10957865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant therapy for breast cancer.
    NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Action and Clinical Relevance of Aromatase Inhibitors.
    Murphy MJ
    Oncologist; 1998; 3(2):129-130. PubMed ID: 10388095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventive health care, 1999 update: 3. Follow-up after breast cancer. Canadian Task Force on Preventive Health Care.
    Temple LK; Wang EE; McLeod RS
    CMAJ; 1999 Oct; 161(8):1001-8. PubMed ID: 10551200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Better treatment for breast cancer in older patients.
    Tran P; Fentiman IS
    Expert Rev Anticancer Ther; 2009 Aug; 9(8):1081-90. PubMed ID: 19671028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current limits of knowledge in adjuvant and neoadjuvant endocrine therapy of breast cancer: the need for more clinical research.
    Hayward RL; Dixon JM
    Surg Oncol; 2003 Dec; 12(4):289-304. PubMed ID: 14998569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can we identify patients with invasive breast cancer adequately treated with breast-conserving surgery alone?
    Schnitt SJ
    Mod Pathol; 1998 Feb; 11(2):129-33. PubMed ID: 9504683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Breast cancer].
    Kobayashi T; Yamazaki H; Nakamura T; Ogihara A; Fujii T; Hirano A; Uno S; Yoshida K; Nagata T; Uchida K; Kubo H; Tozaki M; Kanehira C; Miyazawa Y; Suzuki M; Kuraishi Y
    Gan To Kagaku Ryoho; 2001 Nov; 28(12):1814-25. PubMed ID: 11729473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic breast cancer: understanding current management options.
    McGinn K; Moore J
    Oncol Nurs Forum; 2001 Apr; 28(3):507-12; quiz 513-4. PubMed ID: 11338758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of third-generation aromatase inhibitors and tamoxifen in the adjuvant treatment of postmenopausal patients with hormone-dependent breast cancer: evidence based review.
    Poole R; Paridaens R
    Curr Opin Oncol; 2007 Nov; 19(6):564-72. PubMed ID: 17906453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Primary medical therapy (preoperative therapy) in the treatment of operable breast cancer].
    Taguchi T
    Gan To Kagaku Ryoho; 1996 Nov; 23(13):1733-9. PubMed ID: 8937482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond tamoxifen: extended and late extended endocrine therapy in postmenopausal early breast cancer.
    Dodwell D; Williamson D
    Cancer Treat Rev; 2008 Apr; 34(2):137-44. PubMed ID: 18006236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The randomized trials of dose-intensive therapy for breast cancer: what do they mean for patient care and where do we go from here?
    Weiss RB
    Oncologist; 1999; 4(6):450-8. PubMed ID: 10631689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized clinical trials in breast cancer.
    Klauber-Demore N; Boolbol SK; Derossis AM; Ruo L; Bernik SF; Borgen PI
    Surg Oncol Clin N Am; 2002 Jan; 11(1):53-88, viii. PubMed ID: 11928802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can we cure oligometastatic disease? A practical point of view.
    Pérez-García J; Cortez P; Gion M; Cortés J
    Curr Opin Oncol; 2020 Nov; 32(6):568-574. PubMed ID: 32925203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Big data: Are large prospective randomized trials obsolete in the future?
    Hudis CA
    Breast; 2015 Nov; 24 Suppl 2():S15-8. PubMed ID: 26255742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ten hot issues of breast cancer in diagnosis and therapy in 2018].
    Jiang ZF; Li JB
    Zhonghua Wai Ke Za Zhi; 2018 Feb; 56(2):95-100. PubMed ID: 29397620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.